ACE and hydrops fetalis: Brown et al. [3] indicated that the current treatments for HF patients (beta-blockers, ACE inhibitors, Aldactone, and Entresto) are aimed at developing a reduction in myocardial demand sufficient enough to improve muscle bioenergetics.